外体非编码微RNA在白血病治疗中的潜在使用:系统性审查
Paulina Gil-Kulik1, Natalia Kluz1,2, Dominika Przywara1
1Department of Clinical Genetics, Medical University of Lublin, 11 Radziwillowska Str., 20-080 Lublin, Poland.
Cancers
|December 17, 2024
概括
携带非编码RNA (ncRNA) 的外体是白血病进展和耐药性的关键. 这些外体的ncRNAs显示为新型的白血病诊断,预后和监测的生物标志物具有前途.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 由于白血病的复发和耐药性,白血病仍然是一个挑战,需要新的生物标志物.
- 外体细胞因其在白血病生物学中的作用越来越被认可,影响药物耐药性,转移和免疫逃避.
- 外基因组通过非编码RNA (ncRNA) 促进细胞间通信,影响细胞功能和瘤微环境.
研究的目的:
- 审查外体ncRNAs在白血病中的作用.
- 探索它们作为诊断和预后生物标记物的潜力.
- 讨论它们在治疗中的调节功能,复发,耐药性,转移和免疫状态.
主要方法:
- 文献综述侧重于白血病中的外体ncRNAs.
- 对外体内circRNAs和microRNAs当前研究的分析.
- 检查外体ncRNAs的调节机制和治疗影响.
主要成果:
- 外体ncRNAs,特别是circRNAs和microRNAs,与白血病的发展和进展有关.
- 这些分子与白血病的关键方面有关,包括耐药性,转移和免疫调节.
- 外基因的ncRNA为白血病的各种临床应用提供了作为无细胞生物标志物的潜力.
结论:
- 外基因的ncRNAs是白血病发病的关键参与者,并作为多功能生物标志物具有显著的前景.
- 了解它们的功能可以改善白血病的诊断,预后和治疗策略.
- 向外体ncRNA可能为治疗白血病及其并发症提供新的治疗途径.
相关概念视频
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K